Feature

illumiSonics expanding the limits of tissue imaging with a single scan

Closely held illumiSonics is addressing a significant unmet medical need by redefining tissue imaging with its proprietary multi-laser imaging (MLI) platform, an advanced modality designed for life sciences research...

May 19, 2026

Feature

Adagio delivering first-of-its-kind innovation in cardiac ablation technology

Adagio Medical (NASDAQ: ADGM) is innovating catheter ablation technologies for the treatment of one of the most challenging and underserved areas in electrophysiology—ventricular tachycardia (VT), a dangerous type of...

May 5, 2026

Feature

Niagen Bioscience innovating NAD+-based therapies from healthy aging to pediatric orphan diseases

Niagen Bioscience (NASDAQ: NAGE) is pioneering the research and development of nicotinamide adenine dinucleotide (NAD+)—a vital coenzyme essential to cellular metabolism, energy production, and DNA repair that declines...

April 28, 2026

Feature

MAIA Biotechnology aiming to extend lives through new cancer treatment class with telomere-targeting agent

MAIA Biotechnology (NYSE American: MAIA) is focusing on the development and commercialization of breakthrough telomere-targeting immunotherapies: potential first-in-class drugs with novel mechanisms of action that aim...

April 14, 2026